A survey of women with fragile X syndrome revealed that most identified with a label other than that of…
Steve Bryson, PhD
Steve holds a PhD in biochemistry from the Faculty of Medicine at the University of Toronto, Canada. As a medical scientist for 18 years, he worked in both academia and industry, where his research focused on the discovery of new vaccines and medicines to treat inflammatory disorders and infectious diseases. Steve is a published author in multiple peer-reviewed scientific journals and a patented inventor.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Steve Bryson, PhD
Gene therapy rescued several behavioral and brainwave abnormalities seen in a rat model of fragile X syndrome. Findings from…
Abnormal protein production associated with fragile X syndrome was coupled with altered cell growth that favored fast-growing…
An analysis of proteins in brain tissue from men with advanced fragile X-associated tremor/ataxia syndrome (FXTAS) found an overall decrease in…
Eye-tracking technology has identified atypical visual attention patterns in women who carry the FMR1…
Brain scans in men with fragile X syndrome showed reduced levels of the…
School-aged girls with fragile X syndrome are less aware of bullying than children…
Low levels of pro-inflammatory proteins in the blood suggest that inflammation is not a hallmark of fragile X…
Providing a fragment of the FMRP protein, which is missing in people with fragile X syndrome, eased hyperactivity and…
A tool to assess language, called expressive language sampling (ELS), found that people with…